Innovation Key to Reversing Decline in Routine Cancer Screenings
A new survey reveals declining cancer screening rates among U.S. adults, but shows strong interest in innovative screening methods.
Read More
Search Results for: lung cancer
EXAONE Path 2.0 Next-Generation Precision Medical AI Debuts
LG AI Research has launched EXAONE Path 2.0, a cutting-edge precision medical AI model that predicts gene mutations and biological markers.
Read More
Bronchoscopic Lung-Biopsy Techniques Have Fewer Complications
New multidisciplinary guidelines bronchoscopic lung biopsy techniques offer tissue sampling adequacy comparable to other testing methods.
Read More
Personalis Expands Tempus Strategic Collaboration to Bring Ultra-Sensitive Cancer Recurrence Testing to Colorectal Cancer Patients
Personalis has expanded and extended its partnership with Tempus AI to include colorectal cancer in their NeXT Personal MRD test.
Read More
Oncomine Dx Express Test Receives FDA Approval as a Companion Diagnostic
The FDA has approved Thermo Fisher’s Oncomine Dx Express Test on the Genexus Dx Integrated Sequencer as a companion diagnostic for ZEGFROVY.
Read More